Home / Insights / Retaining the ?Sunshine? in pharmaceutical meetings and events ? A look at dealing with the Sunshine Act in USA

insights-espresso-icon whitepaper

Retaining the ?Sunshine? in pharmaceutical meetings and events ? A look at dealing with the Sunshine Act in USA

Espresso-live Speakers
by Rajeswari Venkatesh
30 June 2014

The Physician Payment Sunshine Act ? Section 6002 of the Patient Protection and Affordable Care Act (PPACA) is the most recent regulation in USA which is impacting the pharmaceutical and medical device industry. It involves reporting of the transfer of value (either in cash or kind) to health care professionals (HCPs) and teaching hospitals from pharmaceutical companies and medical device companies.

SHARE
Linkedin Twitter Facebook
Leave a comment

Please enter a valid name

Post your comment

Please select captcha

Instagram

Get more stories like this

Subscirbe for more news,updates and insights from Beroe

Get Ahead with AI-Enabled Market Insights Schedule a Demo Now

Schedule a Demo Now